Cargando…

Gill S, Vides V, Frey NV, et al. Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia. Blood Adv. 2022;6(21):5774-5785.

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692278/ https://www.ncbi.nlm.nih.gov/pubmed/37889496 http://dx.doi.org/10.1182/bloodadvances.2023011694

Ejemplares similares

Fabrizio VA, Boelens JJ, Mauguen A, et al. Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Adv. 2022;6(7):1961-1968.
Publicado: (2023)

Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731.
Publicado: (2023)

Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
Publicado: (2022)

van Rhee F, Rosenthal A, Kanhai K, et al. Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease. Blood Adv. 2022;6(16):4773-4781.
Publicado: (2023)

Karihtala K, Leivonen S-K, Karjalainen-Lindsberg M-L, et al. Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients. Blood Adv. 2022;6(6):1919-1931.
Publicado: (2023)

Lisi V, Blanchard È, Vladovsky M, et al. Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia. Blood Adv. 2022;6(17):5160-5164.
Publicado: (2023)

Nawas MT, Sanchez-Escamilla M, Devlin SM, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6(22):5898-5907.
Publicado: (2023)

Kudo K, Kubota Y, Toki T, et al. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report. Blood Adv. 2022;6(10):3162-3166.
Publicado: (2022)

Smith CC, Levis MJ, Perl AE, et al. Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib. Blood Adv. 2022;6(7):2144-2155.
Publicado: (2022)

Erratum to “Cardiac Damage Staging Classification in Asymptomatic Moderate or Severe Primary Mitral Regurgitation”: [Structural Heart 2022;6(1):100004]
Publicado: (2023)

Kwiatkowski JL, Hamdy M, El-Beshlawy A, et al. Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Adv. 2022;6(4):1243-1254.
Publicado: (2023)

Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.
Publicado: (2023)

Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, et al. Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood Adv. 2022;6(3):828-847.
Publicado: (2023)

Aiello S, Gastoldi S, Galbusera M, et al. C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19. Blood Adv. 2022;6(3):866-881.
Publicado: (2022)

Frey on the Microscope
Publicado: (1873)

Lissitchkov T, Willemze A, Katragadda S, et al. Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022;6(4):1089-1094.
Publicado: (2022)

Erratum to “A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib”
por: O'Neil, Daniel S., et al.
Publicado: (2018)

Eshel A, Sharon I, Nagler A, et al. Origins of bloodstream infections following fecal microbiota transplantation: a strain-level analysis. Blood Adv. 2022;6(2):568-573.
Publicado: (2022)

Shouval R, Fein JA, Cho C, et al. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT. Blood Adv. 2022;6(5):1525-1535.
Publicado: (2022)

Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
Publicado: (2022)

Łucja Frey (1889–1942)
por: Grzybowski, Andrzej, et al.
Publicado: (2016)

Post Herpetic Frey's Syndrome
por: Shah, Jigna S., et al.
Publicado: (2017)

Frey’s plus versus Frey’s procedure for chronic pancreatitis: Analysis of postoperative outcomes and quality of life
por: Gopalakrishnan, Gunasekaran, et al.
Publicado: (2020)

Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients. Blood. 2020;135(21):1912–1915.
Publicado: (2021)

Visco C, Marcheselli L, Mina R, et al. A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. Blood Adv. (2022);6(1):327-338.
Publicado: (2023)

Kennedy VE, Wong C, Huang C-Y, et al. Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Blood Adv. 2021;5(23):5344-5348.
Publicado: (2023)

Use of botulinum toxin in Frey's syndrome
por: Freni, Francesco, et al.
Publicado: (2019)

Erratum to: Molecular phylogeny of the subfamily Stevardiinae Gill, 1858 (Characiformes: Characidae): classification and the evolution of reproductive traits
por: Thomaz, Andréa T., et al.
Publicado: (2015)

Erratum to “E.C. Lerner, E.S. Srinivasan, G. Broadwater, et al. Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases. Adv Radiat Oncol. 2022;7:101054.”
por: Lerner, Emily Claire, et al.
Publicado: (2023)

Ferroelectric Field‐Effect‐Transistor Integrated with Ferroelectrics Heterostructure (Adv. Sci. 21/2022)
por: Baek, Sungpyo, et al.
Publicado: (2022)

Frey’s Syndrome: A Review of Aetiology and Treatment
por: Mantelakis, Angelos, et al.
Publicado: (2021)

Frey syndrome prevalence after partial parotidectomy
por: Santos, Regiane Cristina, et al.
Publicado: (2015)

Time Rules the Efficacy of Immune Checkpoint Inhibitors in Photodynamic Therapy (Adv. Sci. 21/2022)
por: Wu, Qinghua, et al.
Publicado: (2022)

Erratum to: CAR T Cell Therapy for Hematological Malignancies
por: Yang, Xin, et al.
Publicado: (2021)

NV(–) diamond laser
por: Savvin, Alexander, et al.
Publicado: (2021)

Erratum: SDDF Abstracts 2022
Publicado: (2023)

Role of original and modified Frey's procedures in chronic pancreatitis
por: Tan, Chun-Lu, et al.
Publicado: (2016)

Use of botulinum toxin type A in Frey's syndrome
por: Gualberto, Gustavo Vieira, et al.
Publicado: (2017)

Frey procedure for chronic pancreatitis: A narrative review
por: Ray, Sukanta, et al.
Publicado: (2022)

Forgotten Poles in the history of neurology: from Flatau to Frey
por: Gotowiec, Mateusz
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tv5deq9squc82p6p30nolkladi